You would expect a robust reply to such a forceful article targeting Biotron directly, and if I was an adjudicator of both the article and its response reply at the time, I would say, “only time will tell who is correct “. Well now the passage of time has happened, so who do you think is correct?. Biotron was set up to fund Australian research for possible commercialisation, clearly it has failed this with insufficient funding to continue with BIT225 and Covid, but Michelle still gets her salary plus increase.
BIT Price at posting:
6.0¢ Sentiment: None Disclosure: Not Held
